Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.19
11% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3M | $7.1M | $3.9M | $2.1M | $2.5M | $5.6M | $7.9M | $7.6M |
| Cost of revenue | $432.0K | $665.0K | $345.0K | $209.0K | $420.0K | $847.0K | $1.2M | $622.0K |
| Gross profit | $2.9M | $6.5M | $3.5M | $1.9M | $2.0M | $4.8M | $6.7M | $8.3M |
| Gross margin | 87.0% | 90.7% | 91.1% | 90.0% | 83.0% | 84.9% | 84.6% | 108.4% |
| R&D | $4.0M | $4.4M | $3.1M | $2.1M | $1.3M | $1.3M | $853.0K | $1.3M |
| Operating income | −$7.4M | −$5.5M | −$5.9M | −$5.0M | −$4.8M | $15.0M | $1.7M | −$1.6M |
| EBITDA | −$6.4M | −$4.3M | −$4.2M | −$3.9M | −$3.8M | −$3.9M | $3.6M | $483.0K |
| Net income | −$6.0M | −$4.4M | −$5.1M | −$4.4M | −$4.7M | $11.1M | −$1.3M | −$2.9M |
| Net margin | -181.1% | -61.2% | -131.4% | -210.2% | -190.4% | 197.3% | -15.9% | -38.1% |
| EPS (diluted) | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | 0.03 | -0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11M | $0.02 | $0.02–$0.02 | 1 |
Forward consensus · source: Financial Modeling Prep
NANOCO GROUP PLC ORD
No one on the platform currently holds NNOCF.
No tracked institution reports a position in NNOCF as of their last filing.
No one on the platform has traded NNOCF yet.
| $32M |
| — |
| ISDCFVerimatrix S.A. | $0.39 | +0.00% | $34M | — |
| NOWGNowigence, Inc. | $1.24 | +0.00% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.1× sales vs its 12.6× historical median P/S.
Fair value ≈ $0.44 · price $0.04 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.